Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
Top Cited Papers
Open Access
- 15 January 2009
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 113 (3) , 726-732
- https://doi.org/10.1182/blood-2008-07-171926
Abstract
Survival for patients with acute myeloid leukemia (AML) is limited by treatment-related mortality (TRM) and relapse after unrelated donor (URD) hematKeywords
This publication has 34 references indexed in Scilit:
- Killer cell immunoglobulin‐like receptors on NK cells: the how, where and whyInternational Journal of Immunogenetics, 2007
- High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantationBlood, 2007
- Low Number of Donor Activating Killer Immunoglobulin-Like Receptors (KIR) Genes but not KIR-Ligand Mismatch Prevents Relapse and Improves Disease-Free Survival in Leukemia Patients After In Vivo T-Cell Depleted Unrelated Stem Cell TransplantationTransplantation, 2006
- Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector functionThe Journal of Experimental Medicine, 2006
- Activating Killer Cell Immunoglobulin-Like Receptor Gene KIR2DS1 Is Associated With Psoriatic ArthritisHuman Immunology, 2005
- MHC class I molecules and kirs in human history, health and survivalNature Reviews Immunology, 2005
- The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemiaBlood, 2004
- Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donorsBlood, 2003
- In search of the ‘missing self’: MHC molecules and NK cell recognitionPublished by Elsevier ,2003
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002